Potassium Chloride 15 % Flexivial Fresenius 100 mL Concentrate for solution for infusion.
PDF Leaflet Revision Date: 18 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Potassium deficiency in patients for whom dietary measures or oral medicine are inadequate.
Dosage (summary)
IV infusion after dilution; max 150 mmol/day, 10 mmol/h safe rate.
Special Populations
- Renal impairment
Pregnancy & Breastfeeding
Use in pregnancy if clinically needed; excreted in breast milk, risk to infants possible.
Key Drug Interactions
- Potassium-sparing diuretics
- ACE inhibitors
- NSAIDs
Contraindications
- Hypersensitivity to potassium chloride
- Hyperkalaemia
Common side effects
- Hyperkalaemia
- Nausea
- Pain on injection
Counselling Points
- Monitor serum potassium levels regularly
- Infuse slowly, not exceeding 20 mmol/h
- Avoid potassium-rich foods during treatment
Serious warnings
- Must be diluted before IV infusion
- Risk of cardiac arrest with direct injection
Important Disclaimer
The Potassium Chloride 15 % Flexivial Fresenius 100 mL Concentrate for solution for infusion. professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
